1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Diagnostic accuracy of imaging biomarkers on CTA in determining patients tested for SARS-CoV-2 (n = 106)
Sensitivity (95% CI) Specificity (95% CI) PPV (95% CI) NPV (95% CI) Presence of GGO 75% (56–87) 81% (71–88) 58% (41–74) 90% (79–95) Focal GGO 46% (29–64) 90% (81–95) 62% (39–81) 82% (72–89) Bilateral GGO 57% (37–75) 82% (72–89) 53% (35–71) 84% (73–91) Peripheral GGO 68% (49–82) 88% (79–94) 68% (48–83) 88% (79–94) COVID-19-typical/in-determinatea 64% (46–79) 92% (84–94) 77% (50–92) 88% (74–95)
Note:—PPV indicates positive predictive value; NPV, negative predictive value.
↵a COVID-19-typical alone gave a low sensitivity (36%) and was excluded from further analysis. COVID-19 CT imaging definitions are listed in On-line Table 1.